Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006
<p>Abstract</p> <p>Background</p> <p>Type 2 diabetes is a well-established risk factor for cardiovascular disease and is common among patients with acute myocardial infarction (MI). The extent to which patients with first-time MI develop diabetes requiring glucose-lower...
Main Authors: | Folke Fredrik, Schramm Tina K, Vaag Allan, Andersen Søren S, Hansen Peter, Andersson Charlotte, Norgaard Mette L, Køber Lars, Torp-Pedersen Christian, Gislason Gunnar H |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/10/1/5 |
Similar Items
-
Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study
by: Jørgensen Casper H, et al.
Published: (2010-09-01) -
Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.
by: Anne-Marie Schjerning Olsen, et al.
Published: (2013-01-01) -
Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry
by: Torp-Pedersen Christian, et al.
Published: (2010-06-01) -
Incidence of new onset cancer in patients with a myocardial infarction – a nationwide cohort study
by: Morten Malmborg, et al.
Published: (2018-10-01) -
Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study.
by: Søren Lund Kristensen, et al.
Published: (2013-01-01)